Proper function of the synapse relies on a remarkably precise assemblage of molecular and morphological specializations. However, while much has been learned about the biochemical, structural and physiological features which characterize the mature synapse, much less is known about the mechanisms which direct synapse formation. Agrin is an extracellular matrix protein derived from Torpedo electric organ that organizes acetylcholine receptor (AchR) and acetylcholinesterase (AchE) on cultured myotubes. At the mature neuromuscular junction, immunocytochemical studies have shown that molecules closely related to agrin are highly concentrated in the synaptic basal lamina, a structure known to play a central part in directing synapse regeneration. These results strongly suggest that agrin- related molecules play a role in directing the formation of the regenerating nerve-muscle synapse. The goal of the studies proposed here is to determine how agrin- related molecules might be involved in the differentation of the developing synapse. The experimental plan is to use recently developed monoclonal antibodies to Torpedo agrin to establish the time of appearance and the distribution of agrin-related molecules at the developing chick neuromuscular synapse in vivo. These antibodies will be used in concert with other markers to correlate the localization and expression of agrin-related molecules with other key events in synapse formation, such as the onset of functional innervation and the formation of high density clusters of AchR and AchE. The relationship of the expression and localization of agrin-related molecules to innervation will be investigated in experiments utilizing paralyzed and aneural muscles. These studies should yield important insights into the molecular mechanisms which underlie synapse formation in the developing embryo, and could provide important clues toward developing effective treatments for diseases and trauma which affect the neuromuscular synapse.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD023924-02
Application #
3324319
Study Section
Neurology B Subcommittee 1 (NEUB)
Project Start
1988-08-01
Project End
1991-07-31
Budget Start
1989-08-01
Budget End
1990-07-31
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Worcester Foundation for Biomedical Research
Department
Type
DUNS #
City
Shrewsbury
State
MA
Country
United States
Zip Code
01545
Fallon, Justin R; McNally, Elizabeth M (2018) Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics. Matrix Biol 68-69:616-627
Yilmaz, Atilgan; Kattamuri, Chandramohan; Ozdeslik, Rana N et al. (2016) MuSK is a BMP co-receptor that shapes BMP responses and calcium signaling in muscle cells. Sci Signal 9:ra87
Young, Marian F; Fallon, Justin R (2012) Biglycan: a promising new therapeutic for neuromuscular and musculoskeletal diseases. Curr Opin Genet Dev 22:398-400
Amenta, Alison R; Creely, Hilliary E; Mercado, Mary Lynn T et al. (2012) Biglycan is an extracellular MuSK binding protein important for synapse stability. J Neurosci 32:2324-34
Amenta, Alison R; Yilmaz, Atilgan; Bogdanovich, Sasha et al. (2011) Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice. Proc Natl Acad Sci U S A 108:762-7
Fallon, Justin R (2011) Calcium channels put synapses in their place. Nat Neurosci 14:536-8
Peat, Rachel A; Gecz, Jozef; Fallon, Justin R et al. (2008) Exclusion of biglycan mutations in a cohort of patients with neuromuscular disorders. Neuromuscul Disord 18:606-9
Mercado, Mary Lynn; Amenta, Alison R; Hagiwara, Hiroki et al. (2006) Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS. FASEB J 20:1724-6
Campagna, J A; Fallon, J (2006) Lipid rafts are involved in C95 (4,8) agrin fragment-induced acetylcholine receptor clustering. Neuroscience 138:123-32
Rafii, Michael S; Hagiwara, Hiroki; Mercado, Mary Lynn et al. (2006) Biglycan binds to alpha- and gamma-sarcoglycan and regulates their expression during development. J Cell Physiol 209:439-47

Showing the most recent 10 out of 29 publications